Back

Results - Announcements

Sales rise 11.36% to Rs 187.28 crore

Lincoln Pharmaceuticals consolidated net profit rises 0.43% in the March 2026 quarter

29-May-2026, 07:40
Net profit of Lincoln Pharmaceuticals rose 0.43% to Rs 11.63 crore in the quarter ended March 2026 as against Rs 11.58 crore during the previous quarter ended March 2025. Sales rose 11.36% to Rs 187.28 crore in the quarter ended March 2026 as against Rs 168.18 crore during the previous quarter ended March 2025.

For the full year,net profit rose 6.73% to Rs 87.89 crore in the year ended March 2026 as against Rs 82.35 crore during the previous year ended March 2025. Sales rose 7.67% to Rs 671.03 crore in the year ended March 2026 as against Rs 623.23 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	187.28	168.18	11	671.03	623.23	8
OPM %	13.27	15.89	-	14.56	16.28	-
PBDT	20.39	19.47	5	130.12	122.09	7
PBT	16.70	16.25	3	115.63	109.19	6
NP	11.63	11.58	0	87.89	82.35	7